Fluid Percussion Injury (FPI) Model Development Service
Are you currently facing limited translational success in Traumatic Brain Injury (TBI) research or variability in your preclinical models leading to long drug development cycles? Our Fluid Percussion Injury (FPI) model development services help you accelerate TBI research and obtain highly relevant and reproducible preclinical data through advanced FPI model expertise and comprehensive phenotypic characterization.
TBI poses a major health challenge, necessitating robust preclinical models for therapeutic advancement. FPI is a highly characterized and widely accepted experimental model that precisely replicates key pathological features and behavioral deficits of human TBI. Its controlled nature and scalability make it invaluable for investigating underlying mechanisms and evaluating novel neuroprotective and neurorestorative agents. Creative Biolabs leverages its extensive expertise to offer bespoke FPI model development, ensuring high-fidelity data to accelerate your preclinical success.
How Our FPI Model Development Services Can Assist Your Project?
At CBL, our FPI model development services offer a precise and customizable platform for unraveling the complexities of TBI and evaluating novel therapeutic interventions. We provide researchers with meticulously characterized injury models that accurately reflect human TBI pathologies and behavioral deficits. Our solutions deliver reliable and translatable data, crucial for advancing your drug discovery and development programs. From initial model design to comprehensive data analysis, we ensure every step supports your project's success.
Discover How We Can Help - Request a Consultation today!
Workflow: Precision in Every Step
Our workflow is designed for clarity, efficiency, and scientific rigor, ensuring seamless project execution and optimal outcomes.
- Required Starting Materials: To initiate your FPI model development project, clients typically provide:
- Detailed project goals and specific research questions.
- Information on target compounds or therapeutic strategies to be evaluated.
- Relevant background literature or preliminary data pertaining to your investigation.
- Final Deliverables: Upon project completion, clients receive:
- A detailed Project Report summarizing experimental design, methodologies, and raw data.
- Comprehensive Data Analyses and Interpretations, including statistical summaries and graphical representations.
- Translational Insights and Strategic Recommendations for future research directions.
- Estimated Timeframe: The typical timeframe for FPI model development and characterization ranges from 8 to 24 weeks, depending on the complexity of the study design, the number of experimental groups, and the duration of longitudinal assessments required for chronic injury evaluation.
Why Choose Us?
Choosing CBL for your FPI model development services means collaborating with a leader in neurotrauma research, committed to delivering excellence and accelerating your therapeutic breakthroughs. Our unparalleled expertise, rigorous quality control, and client-centric approach set us apart.
- Unrivaled Scientific Acumen: With over two decades of specialized experience, our team comprises leading neuroscientists who bring an intimate understanding of TBI pathophysiology to every project, ensuring your research is guided by cutting-edge knowledge.
- Superior Reproducibility & Quality: We adhere to stringent Standard Operating Procedures (SOPs) and implement meticulous execution and robust quality control measures. This commitment guarantees highly reproducible and reliable data, the absolute bedrock of impactful, translational research, directly addressing the variability challenges often associated with FPI models.
- Customization & Flexibility: We recognize that no two research questions are identical. Our services are highly adaptable, offering bespoke FPI model designs tailored precisely to your unique experimental requirements, including specific injury severities and locations (lateral or midline).
- Accelerated Timelines: Our optimized workflows and dedicated resources ensure efficient project execution, significantly expediting your research timelines and bringing novel neuroprotective therapies closer to clinical application.
- Integrated End-to-End Solutions: From initial model design and precision surgical induction to comprehensive phenotypic characterization, advanced imaging (including MRI/MRS), and insightful data analysis, we offer a seamless, integrated solution that streamlines your entire research pipeline.
Experience the Advantage - Get a Quote Today!
Fluid Percussion Injury (FPI) Model
The FPI model is a gold standard in controlled brain trauma research, providing a highly reproducible method to induce TBI in experimental animals. This model involves delivering a brief, controlled fluid pulse to the intact dura through a craniotomy. The injury is typically produced by a pendulum striking a piston within a cylindrical fluid reservoir, generating a pressure wave that transmits to the brain tissue. This mechanism allows for precise control over injury parameters, including pressure, duration, and the site of impact (lateral, central, or midline), enabling the study of both focal and diffuse injury pathologies.
The FPI model faithfully recapitulates numerous aspects of human TBI. Pathologically, it induces key features such as axonal injury, neuroinflammation, neuronal cell loss, glial activation (astrogliosis and microgliosis), and blood-brain barrier disruption. Physiologically, it can replicate acute hypertension, bradycardia, increased plasma glucose levels, suppression of electroencephalogram (EEG) amplitude, and hemorrhaging at the gray-white matter interface. Functionally, FPI leads to persistent impairments in spatial learning and memory, cognitive deficits, and motor learning deficits, providing a comprehensive platform for evaluating therapeutic efficacy over acute and chronic phases. While highly versatile and applicable across various species (including rodents, rabbits, cats, and pigs), careful execution is paramount to minimize variability due to operational factors like craniotomy placement or air bubbles in the system, ensuring the reliability of generated data.
What We Can Offer
At CBL, our FPI model development services are meticulously designed to meet the rigorous demands of preclinical TBI research. We offer tailored solutions that combine scientific excellence with practical efficiency, providing you with a distinct advantage in your therapeutic development efforts.
- Customized FPI Model Design: We provide bespoke FPI model paradigms, meticulously adapting injury severity (mild, moderate, severe) and location (lateral or midline) to precisely align with your unique research objectives and therapeutic compounds.
- End-to-End Service: Benefit from a seamless, one-stop solution from initial project consultation and precise surgical execution to comprehensive phenotypic characterization and expert data analysis, streamlining your research pipeline with CBL.
- Robust Quality Assurance: Our services are underpinned by a well-established quality system, integrating Quality-by-Design (QbD) principles and stringent aseptic verification procedures throughout the FPI induction and experimental process, ensuring data integrity and reproducibility.
- Scalable Study Capabilities: Whether you require small-scale pilot studies or large-scale, complex therapeutic evaluations with multiple cohorts, CBL has the capacity and expertise to support projects of varying scopes and complexities.
- Optimized Experimental Conditions: We continuously optimize injury induction protocols and post-injury management to maximize the relevance and fidelity of the FPI model, ensuring the highest yield of meaningful data for your specific research questions.
- Comprehensive Data Delivery: Receive highly detailed and interpretable final deliverables, including extensive raw data, statistical analyses, and strategic insights, enabling robust decision-making and accelerating your path to publication or clinical translation.
Related Services
To further support your comprehensive neurotrauma research, CBL offers a suite of complementary services designed to provide integrated solutions:
- Neuroinflammation Research Services
- Blood-Brain Barrier (BBB) Integrity Assessment
- Cognitive and Behavioral Phenotyping Platforms
- Target Validation & Drug Screening
Contact Our Team for More Information and to Discuss Your Project.
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
